Investigation of in vivo fatty acid metabolism in AFABP/aP2(-/-) mice

American Journal of Physiology. Endocrinology and Metabolism
Rachel A BaarElizabeth J Parks

Abstract

The metabolic impact of the murine adipocyte fatty acid-binding protein (AFABP/aP2) on lipid metabolism was investigated in the AFABP/aP2(-/-) mouse and compared with wild-type C57BL/6J littermates. Mice were weaned on a high-fat diet (59% of energy from fat) and acclimated to meal feeding. Stable isotopes were administered, and indirect calorimetry was performed to quantitate fatty acid flux, dietary fatty acid utilization, and substrate oxidation. Consistent with previous in situ and in vitro studies, fasting serum nonesterified fatty acid (NEFA) release was significantly reduced in AFABP/aP2(-/-) (17.1 +/- 9.0 vs. 51.9 +/- 22.9 mg.kg(-1).min(-1)). AFABP/aP2(-/-) exhibited higher serum NEFA (1.4 +/- 0.6 vs. 0.8 +/- 0.4 mmol/l, AFABP/aP2(-/-) vs. C57BL/6J, respectively) and triacylglycerol (TAG; 0.23 +/- 0.09 vs. 0.13 +/- 0.10 mmol/l) and accumulated more TAG in liver tissue (2.9 +/- 2.3 vs. 1.1 +/- 0.8% wet wt) in the fasted state. For the liver-TAG pool, 16.4 +/- 7.3% of TAG-fatty acids were derived from serum NEFA in AFABP/aP2(-/-). In contrast, a significantly greater portion of C57BL/6J liver-TAG was derived from serum NEFA (42.3 +/- 25.5%) during tracer infusion. For adipose-TAG stores, only 0.29 +/- 0.04% was derived fr...Continue Reading

References

Nov 1, 1990·Lipids·A OhtaW E Lands
Jan 1, 1987·Annual Review of Nutrition·E JéquierY Schutz
Oct 1, 1994·The Journal of Clinical Investigation·G S HotamisligilB M Spiegelman
Jun 1, 1994·Current Opinion in Lipidology·G F Gibbons
Jan 1, 1997·Annual Review of Nutrition·D A BernlohrL J Banaszak
Jun 20, 1998·Biochimica Et Biophysica Acta·N R Coe, D A Bernlohr
Oct 15, 1998·The American Journal of Clinical Nutrition·E J ParksB O Schneeman
May 13, 1999·Proceedings of the National Academy of Sciences of the United States of America·W J ShenF B Kraemer
Jun 4, 1999·Seminars in Cell & Developmental Biology·D A BernlohrV J LiCata
Jun 11, 1999·The American Journal of Physiology·M K Hellerstein, R A Neese
Oct 19, 1999·The Journal of Clinical Investigation·E J ParksM K Hellerstein
Jun 17, 2000·Trends in Endocrinology and Metabolism : TEM·A V Hertzel, D A Bernlohr
Aug 31, 2000·Endocrinology·K T UysalG S Hotamisligil
Dec 29, 2000·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·G S Hotamisligil
Feb 13, 2001·Trends in Biochemical Sciences·D A OkarA J Lange
Apr 1, 1959·Journal of Neurochemistry·M LEESS CARR

❮ Previous
Next ❯

Citations

Jun 2, 2011·Chemical Reviews·Rosalind A Coleman, Douglas G Mashek
Sep 17, 2009·Journal of Medicinal Chemistry·Ann V HertzelDavid A Bernlohr
Jun 16, 2011·International Journal of Obesity : Journal of the International Association for the Study of Obesity·A Girousse, D Langin
Mar 26, 2009·The Journal of Biological Chemistry·Brian R ThompsonDavid A Bernlohr
Apr 26, 2008·Annual Review of Nutrition·Judith Storch, Betina Corsico
Dec 2, 2010·American Journal of Physiology. Endocrinology and Metabolism·David P MacfarlaneBrian R Walker
Nov 3, 2011·Endocrinology·Shoba ShettyElizabeth J Parks
Jun 26, 2013·Future Medicinal Chemistry·Aimalie L Hardaway, Izabela Podgorski
Aug 22, 2006·European Journal of Clinical Investigation·D Stejskal, M Karpisek
Nov 14, 2007·Metabolism: Clinical and Experimental·Thomas ReinehrChristian L Roth
Jul 29, 2008·Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology·Yoshiyuki MatsubaraKoichiro Kano
May 27, 2017·Journal of Lipid Research·Ann V HertzelDavid A Bernlohr
Oct 19, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Giovanni MussoGianfranco Pagano
Nov 1, 2016·Molecular and Cellular Biology·Kaylee A SteenDavid A Bernlohr
Apr 18, 2014·International Journal of Cancer. Journal International Du Cancer·Hisanori UeharaKeisuke Izumi
May 15, 2007·Current Opinion in Lipidology·Peter Arner, Dominique Langin
Jan 3, 2006·Current Hypertension Reports·Bert Binas
Jul 2, 2005·Current Opinion in Lipidology·Keith N FraynFredrik Karpe
Nov 24, 2005·American Journal of Physiology. Endocrinology and Metabolism·Ann V HertzelDavid A Bernlohr
Oct 24, 2013·Aging Clinical and Experimental Research·Marco MasettiMarco Zoli
Mar 23, 2017·The Journal of Clinical Endocrinology and Metabolism·Kyoung Eun JoungChristos S Mantzoros
Apr 7, 2020·Journal of the American Heart Association·Obiora EgbucheKenneth J Mukamal
Dec 6, 2014·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Brenda S HijmansMaaike H Oosterveer
Dec 13, 2006·Clinical Science·Celia G WalkerMary C Sugden
Feb 11, 2015·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Yuan-yuan LiJiang-feng Mao
Feb 1, 2014·Bioscience Reports·Zhouchun ShangHui Li
Sep 2, 2019·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Xiaojin ZhangYongju Luo
Apr 6, 2021·Frontiers in Immunology·Chi-Ho LeeKaren S L Lam
Jul 25, 2006·Comptes rendus biologies·Dominique Langin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.